Lincosamides
- Auxe Pharma
- May 24
- 3 min read
Updated: May 25
Lincosamides may not be frontline antibiotics in community practice, but they’re a crucial option for patients with β-lactam allergies and for anaerobic coverage. Pharmacists—especially interns—must understand their nuances, toxicities, and proper use to optimise patient outcomes and avoid harm.
General Principles of Link:
Medicine Link
Summary Snapshot – Intern Pharmacist Quick Table
Drug | Route | Use | Key Risks | Key Tip |
Clindamycin | Oral/IV/topical | β-lactam allergy, anaerobes | Diarrhoea, C. difficile | Monitor with long use |
Lincomycin | IV/IM only | β-lactam allergy | Cross-resistance, limited activity | Rarely used |
Clinda + Tretinoin | Topical | Inflammatory acne | Sun sensitivity, dryness | Use sunscreen, short-term only |
Mechanism of Action
Both clindamycin and lincomycin are bacteriostatic antibiotics that:
Inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit
Exhibit cross-resistance with macrolides and each other
Are active mainly against Gram-positive cocci and anaerobes
Where They Fit In
Drug | Routes | Brands (AU) | Common Use |
Clindamycin | Oral, IV, Topical, Vaginal | Dalacin C®, Clindagel® | Skin, bone, dental, PJP, BV |
Lincomycin | IV/IM only | Lincomycin Sandoz® | Rarely used – severe β-lactam allergy |
Clinical Indications
Clinical Use | Notes |
Penicillin/cephalosporin allergy | For skin, soft tissue, dental, aspiration pneumonia |
Anaerobic infections | Particularly intra-abdominal or aspiration-related |
Bacterial vaginosis (BV) | Oral or topical clindamycin |
Toxoplasma encephalitis | Combined with pyrimethamine |
PJP (Pneumocystis jirovecii pneumonia) | With primaquine |
Surgical/endocarditis prophylaxis | In select high-risk β-lactam-allergic patients |
Topical acne | With or without tretinoin |
Use in Special Populations
Group | Recommendation |
Pregnancy | ✅ Safe (clindamycin) – except clindamycin+tretinoin combo (avoid due to retinoid) |
Breastfeeding | ✅ Safe – may cause mild infant diarrhoea |
Children | Use weight-based dosing; watch for C. difficile |
Renal/Hepatic Impairment | Monitor with prolonged use (esp. >10 days) |
Adverse Effects – What Pharmacists Should Watch For
Type | Common | Infrequent | Rare |
GI | Diarrhoea, nausea, abdominal cramps | C. difficile colitis | Liver injury, AKI |
Skin | Rash, itch | – | SJS, TEN |
Systemic | – | – | Anaphylaxis, blood dyscrasias |
IV-specific | – | Thrombophlebitis | Hypotension/cardiac arrest (rapid injection) |
IM-specific | – | Injection site pain | Sterile abscess |
Dosing Summary – Clindamycin

Indication | Adult Dose | Route |
General infections | 150–450 mg q6–8h | Oral |
Severe infections | 600–2700 mg/day in 2–4 doses (max 4800 mg/day) | IV |
Dental infections | 300–450 mg q8h for 5–7 days | Oral |
PJP | 450–600 mg q6–8h | Oral/IV |
Toxoplasmosis | 600 mg q6h (treatment) | IV |
Bacterial vaginosis | 300 mg BD × 7 days | Oral |
Endocarditis prophylaxis | 600 mg 1–2 hrs before procedure | Oral/IV |
Surgical prophylaxis | 600 mg IV within 2 hrs of incision | IV |
Children (Oral): 5–10 mg/kg q8h (max 450 mg)
Children (IV/IM): 5–15 mg/kg q8h (max 600 mg)

Practice Tips
Full cross-resistance: clindamycin ↔ lincomycin
Partial cross-resistance with macrolides (check if Staph/Strep resistant)
C. difficile risk: Clindamycin has higher risk than many antibiotics
No commercial oral liquid: For paediatrics, dissolve capsule powder in water/juice
Topical clindamycin: Effective in acne – but use short-term to reduce resistance
Topical Combination – Clindamycin + Tretinoin (Acnatac®)

✅ Use: Inflammatory acne (pustules, comedones)
Dose: Apply thin layer once daily at bedtime
Tips:
Wash & dry face before use
Use sunscreen daily (tretinoin increases UV sensitivity)
Stop combo when inflammation clears; continue tretinoin alone for maintenance
Avoid in pregnancy
Counselling Points – Clindamycin (Oral/IV/Topical)
Form | Key Advice |
Oral | Take with food + full glass of water; report diarrhoea |
IV | Infuse slowly (≤30 mg/min); monitor BP |
Topical (Acne) | Apply thinly; avoid eyes/mouth; expect mild dryness |
Vaginal | Apply at bedtime; avoid intercourse during use |
Monitoring Parameters
CBC, renal, and hepatic function if:
Using >10 days
High doses or IV therapy
Watch for C. difficile symptoms even weeks after stopping
Commentaires